A detailed history of Chicago Capital, LLC transactions in Insulet Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 168,434 shares of PODD stock, worth $44.9 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
168,434
Previous 162,877 3.41%
Holding current value
$44.9 Million
Previous $32.9 Million 19.27%
% of portfolio
1.1%
Previous 0.99%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$180.69 - $239.01 $1 Million - $1.33 Million
5,557 Added 3.41%
168,434 $39.2 Million
Q2 2024

Aug 06, 2024

SELL
$161.02 - $206.98 $702,208 - $902,639
-4,361 Reduced 2.61%
162,877 $32.9 Million
Q1 2024

Apr 15, 2024

BUY
$163.6 - $209.11 $10.1 Million - $12.9 Million
61,628 Added 58.35%
167,238 $28.7 Million
Q4 2023

Jan 22, 2024

BUY
$127.77 - $221.42 $3.16 Million - $5.48 Million
24,747 Added 30.6%
105,610 $22.9 Million
Q3 2023

Oct 25, 2023

BUY
$154.67 - $290.89 $12.5 Million - $23.5 Million
80,863 New
80,863 $12.9 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.